Timolol exhibits significantly greater beta-blocking potency than propranolol. Both drugs demonstrate clinical practicality for twice-daily dosing in patients with coronary artery disease and healthy subjects.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: